MOA Life Plus Co. Ltd. Logo

MOA Life Plus Co. Ltd.

Develops biopharmaceuticals and consumer healthcare products using γ-PGA technology.

142760 | KO

Overview

Corporate Details

ISIN(s):
KR7142760008
LEI:
Country:
South Korea
Address:
경기도 용인시 수지구 신수로 767 7층 (동천동, 분당수지유타워 지식산업센터), 용인시

Description

MOA Life Plus Co. Ltd. is a biopharmaceutical company that researches and develops innovative medicines and consumer healthcare products. The company's pharmaceutical division focuses on a pipeline of biopharmaceuticals, including immunotherapies, cancer treatments, and vaccines for infectious diseases. A core platform technology utilizes Gamma-Polyglutamic Acid (γ-PGA), a natural amino acid polymer derived from fermented foods, to enhance immune responses and serve as a vaccine adjuvant. The consumer business division provides tailored healthcare solutions for immunity enhancement, skin rejuvenation, and pet care. It also manufactures and supplies γ-PGA-based raw materials for the cosmetics industry.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2022-03-31 00:00
교환청구권행사
Korean 11.5 KB
2022-03-29 00:00
주식등의대량보유상황보고서(약식)
Korean 62.2 KB
2022-03-29 00:00
투자판단관련주요경영사항(자궁경부전암에 대한 치료제 BLS-ILB-E710c의 유효성 확증을 위한 다기관, 이중눈가림, 층화 블록 무작위 배정,…
Korean 10.9 KB
2022-03-23 00:00
감사보고서제출
Korean 24.0 KB
2022-03-23 00:00
사업보고서 (2021.12)
Korean 599.9 KB
2022-03-22 00:00
투자판단관련주요경영사항(중등증 코로나바이러스감염증-19 (COVID-19) 환자를 대상으로 BLS-H01의 유효성과 안전성을 평가하기 위한 다…
Korean 12.7 KB
2022-03-18 00:00
[기재정정]의결권대리행사권유참고서류
Korean 149.1 KB
2022-03-16 00:00
주주총회소집결의
Korean 11.5 KB
2022-03-16 00:00
주주총회집중일개최사유신고
Korean 4.7 KB
2022-03-16 00:00
주주총회소집공고
Korean 161.2 KB
2022-03-16 00:00
의결권대리행사권유참고서류
Korean 144.2 KB
2022-03-04 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 21.3 KB
2022-03-03 00:00
투자판단관련주요경영사항(중등도 코로나바이러스감염증-19 (COVID-19) 환자를 대상으로 BLS-H01 유효성과 안전성을 평가하기 위한 다기…
Korean 12.2 KB
2022-03-02 00:00
교환가액의조정
Korean 10.9 KB
2022-02-18 00:00
전환청구권행사
Korean 8.3 KB

Automate Your Workflow. Get a real-time feed of all MOA Life Plus Co. Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for MOA Life Plus Co. Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for MOA Life Plus Co. Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.